UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 16, 2021

 

 

Build Acquisition Corp.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-40220   86-1389419

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

3300 Jefferson Street, Suite 303  
Austin, TX   78731
(Address of principal executive offices)   (Zip Code)

(512) 994-2983

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant   BGSX.U   New York Stock Exchange
Class A common stock, par value $0.0001 per share   BGSX   New York Stock Exchange
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50   BGSX WS   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 1.01 Entry into a Material Definitive Agreement.

On March 16, 2021, the registration statement on Form S-1 (File No. 333-253664) (the “Registration Statement”) relating to the initial public offering (the “IPO”) of Build Acquisition Corp. (the “Company”) was declared effective by the U.S. Securities and Exchange Commission.

On March 19, 2021, the Company consummated the IPO of 20,000,000 units (“Units”). Each Unit consists of one share of Class A common stock of the Company, par value $0.0001 per share (“Class A Common Stock”), and one-third of one redeemable warrant of the Company, each whole warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $200,000,000.

In connection with the IPO, the Company entered into the following agreements, the forms of which were previously filed as exhibits to the Registration Statement:

 

 

An Underwriting Agreement, dated March 16, 2021, among the Company and Cowen and Company, LLC and Allen & Company LLC, as representatives of the underwriters, a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference;

 

 

A Warrant Agreement, dated March 16, 2021, between the Company and Continental Stock Transfer & Trust Company, as warrant agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference;

 

 

A Letter Agreement, dated March 16, 2021, among the Company, Build Acquisition Sponsor LLC (the “Sponsor”) and each of the Company’s executive officers and directors, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference;

 

 

An Investment Management Trust Agreement, dated March 16, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference;

 

 

A Registration Rights Agreement, dated March 16, 2021, among the Company, the Sponsor and certain other security holders named therein, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference;

 

 

An Administrative Services Agreement, dated March 16, 2021, between the Company and BuildGroup LLC, an affiliate of the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference;

 

 

A Sponsor Warrants Purchase Agreement, dated March 16, 2021, between the Company and the Sponsor, a copy of which is attached as Exhibit 10.5 hereto and incorporated herein by reference;

 

 

An Indemnity Agreement, dated March 16, 2021, between the Company and A. Lanham Napier, a copy of which is attached as Exhibit 10.6 hereto and incorporated herein by reference;

 

 

An Indemnity Agreement, dated March 16, 2021, between the Company and Zeynep Young, a copy of which is attached as Exhibit 10.7 hereto and incorporated herein by reference;

 

 

An Indemnity Agreement, dated March 16, 2021, between the Company and Tanner Cerand, a copy of which is attached as Exhibit 10.8 hereto and incorporated herein by reference;

 

 

An Indemnity Agreement, dated March 16, 2021, between the Company and Owen Van Natta, a copy of which is attached as Exhibit 10.9 hereto and incorporated herein by reference;

 

2


 

An Indemnity Agreement, dated March 16, 2021, between the Company and Noam Ohana, a copy of which is attached as Exhibit 10.10 hereto and incorporated herein by reference; and

 

 

An Indemnity Agreement, dated March 16, 2021, between the Company and James Weaver, a copy of which is attached as Exhibit 10.11 hereto and incorporated herein by reference.

Item 3.02 Unregistered Sales of Equity Securities.

Substantially concurrently with the consummation of the IPO, the Company completed the private sale of 4,000,000 warrants (the “Private Placement Warrants”) at a purchase price of $1.50 per Private Placement Warrant, to the Sponsor, generating gross proceeds to the Company of $6,000,000. The Private Placement Warrants are identical to the warrants sold as part of the Units in the IPO except that, so long as they are held by the Sponsor or its permitted transferees: (1) they will not be redeemable by the Company (except in certain redemption scenarios when the price per share of Class A Common Stock equals or exceeds $10.00 (as adjusted)); (2) they (including the shares of Class A Common Stock issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the Company’s initial business combination; (3) they may be exercised by the holders on a cashless basis; and (4) they (including the shares of Class A Common Stock issuable upon exercise of these warrants) are entitled to registration rights.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective as of March 16, 2021, the following individuals were appointed to the board of directors of the Company: Owen Van Natta, Noam Ohana and James Weaver. Additional information regarding, among other things, each individual’s background, board committee membership and compensatory arrangements is contained in the Registration Statement and is incorporated herein by reference.

Item 5.03 Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year.

On March 16, 2021, the Company filed its amended and restated certificate of incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware. The terms of the Certificate of Incorporation are set forth in the Registration Statement and are incorporated herein by reference. The foregoing description of the Certificate of Incorporation is qualified in its entirety by reference to the full text of the Certificate of Incorporation, which is attached as Exhibit 3.1 hereto and is incorporated herein by reference.

Item 8.01 Other Events.

A total of $200,000,000, comprised of proceeds from the IPO and the sale of the Private Placement Warrants, was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay its taxes, if any, the funds held in the trust account will not be released from the trust account until the earliest to occur of: (1) the completion of the Company’s initial business combination; (2) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Certificate of Incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial business combination or to redeem 100% of its public shares if the Company does not complete its initial business combination within 24 months from the closing of the IPO or (B) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity; and (3) the redemption of the Company’s public shares if the Company has not completed its initial business combination within 24 months from the closing of the IPO, subject to applicable law.

On March 16, 2021, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 hereto and incorporated herein by reference.

On March 19, 2021, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 hereto and incorporated herein by reference.

 

3


Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are filed with this Form 8-K:

 

Exhibit No.

  

Description of Exhibits

  1.1    Underwriting Agreement, dated March 16, 2021, among the Company, and Cowen and Company, LLC and Allen & Company LLC.
  3.1    Amended and Restated Certificate of Incorporation of the Company.
  4.1    Warrant Agreement, dated March 16, 2021, between the Company and Continental Stock Transfer & Trust Company, as warrant agent.
10.1    Letter Agreement, dated March 16, 2021, among the Company, the Sponsor and the Company’s officers and directors.
10.2    Investment Management Trust Agreement, dated March 16, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee.
10.3    Registration Rights Agreement, dated March 16, 2021, among the Company, the Sponsor and certain other security holders named therein.
10.4    Administrative Services Agreement, dated March 16, 2021, between the Company and BuildGroup LLC.
10.5    Sponsor Warrants Purchase Agreement, dated March 16, 2021, between the Company and the Sponsor.
10.6    Indemnity Agreement, dated March 16, 2021, between the Company and A. Lanham Napier.
10.7    Indemnity Agreement, dated March 16, 2021, between the Company and Zeynep Young.
10.8    Indemnity Agreement, dated March 16, 2021, between the Company and Tanner Cerand.
10.9    Indemnity Agreement, dated March 16, 2021, between the Company and Owen Van Natta.
10.10    Indemnity Agreement, dated March 16, 2021, between the Company and Noam Ohana.
10.11    Indemnity Agreement, dated March 16, 2021, between the Company and James Weaver.
99.1    Press Release, dated March 16, 2021.
99.2    Press Release, dated March 19, 2021.

 

4


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Build Acquisition Corporation
Date: March 19, 2021     By:   /s/ Zeynep Young
    Name:   Zeynep Young
    Title:   Co-Chief Executive Officer and Director

 

5